Home LiteratureArticle Details
PMID: 16457729 Published · epublish English Journal Article Research Support, N.I.H., Extramural

A suboptimal 5' splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication.

Retrovirology ·Vol. 3 ·2006-02-03 ·Pages 10

Madsen JM, Stoltzfus CM

Abstract

Inefficient alternative splicing of the human immunodeficiency virus type 1(HIV-1) primary RNA transcript results in greater than half of all viral mRNA remaining unspliced. Regulation of HIV-1 alternative splicing occurs through the presence of suboptimal viral 5' and 3' splice sites (5' and 3'ss), which are positively regulated by exonic splicing enhancers (ESE) and negatively regulated by exonic splicing silencers (ESS) and intronic splicing silencers (ISS). We previously showed that splicing at HIV-1 3'ss A2 is repressed by ESSV and enhanced by the downstream 5'ss D3 signal. Disruption of ESSV results in increased vpr mRNA accumulation and exon 3 inclusion, decreased accumulation of unspliced viral mRNA, and decreased virus production. Here we show that optimization of the 5'ss D2 signal results in increased splicing at the upstream 3'ss A1, increased inclusion of exon 2 into viral mRNA, decreased accumulation of unspliced viral mRNA, and decreased virus production. Virus production from the 5'ss D2 and ESSV mutants was rescued by transient expression of HIV-1 Gag and Pol. We further show that the increased inclusion of either exon 2 or 3 does not significantly affect the stability of viral mRNA but does result in an increase and decrease, respectively, in HIV-1 mRNA levels. The changes in viral mRNA levels directly correlate with changes in tat mRNA levels observed upon increased inclusion of exon 2 or 3. These results demonstrate that splicing at HIV-1 3'ss A1 is regulated by the strength of the downstream 5'ss signal and that suboptimal splicing at 3'ss A1 is necessary for virus replication. Furthermore, the replication defective phenotype resulting from increased splicing at 3'ss A1 is similar to the phenotype observed upon increased splicing at 3'ss A2. Further examination of the role of 5'ss D2 and D3 in the alternative splicing of 3'ss A1 and A2, respectively, is necessary to delineate a role for non-coding exon inclusion in HIV-1 replication.

MeSH Terms
Alternative Splicing Base Sequence Cell Line DNA Primers Enhancer Elements, Genetic Exons Gene Products, vif/immunology Gene Products, vpr/immunology HIV-1/genetics,physiology HeLa Cells Humans Molecular Sequence Data Oligonucleotides, Antisense Plasmids RNA, Messenger/genetics RNA, Viral/genetics Virus Replication vif Gene Products, Human Immunodeficiency Virus vpr Gene Products, Human Immunodeficiency Virus
Chemicals
DNA Primers Gene Products, vif Gene Products, vpr Oligonucleotides, Antisense RNA, Messenger RNA, Viral vif Gene Products, Human Immunodeficiency Virus vpr Gene Products, Human Immunodeficiency Virus
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Madsen Joshua M
Interdisciplinary Program in Molecular Biology, University of Iowa, Iowa City, IA 52242, USA. [email protected]
Stoltzfus C Martin
References (26)
26 references, click to expand
  1. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
    Gene Ther. 1995 Jun;2(4):269-78 PMID: 7552987
  2. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
    Virology. 1995 Nov 10;213(2):373-85 PMID: 7491762
  3. Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3' splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2.
    Nucleic Acids Res. 1997 Feb 15;25(4):861-7 PMID: 9016638
  4. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system.
    Gene Ther. 1999 May;6(5):715-28 PMID: 10505094
  5. Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNA.
    J Biol Chem. 2005 Mar 4;280(9):8581-8 PMID: 15611123
  6. Determinants of the inherent strength of human 5' splice sites.
    RNA. 2005 May;11(5):683-98 PMID: 15840817
  7. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing.
    Immunity. 2005 May;22(5):607-19 PMID: 15894278
  8. An exonic splicing silencer downstream of the 3' splice site A2 is required for efficient human immunodeficiency virus type 1 replication.
    J Virol. 2005 Aug;79(16):10478-86 PMID: 16051840
  9. Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains.
    J Virol. 1999 Dec;73(12):9764-72 PMID: 10559286
  10. Conserved stem-loop structures in the HIV-1 RNA region containing the A3 3' splice site and its cis-regulatory element: possible involvement in RNA splicing.
    Nucleic Acids Res. 2001 Jan 15;29(2):464-78 PMID: 11139617
  11. The sequence complementarity between HIV-1 5' splice site SD4 and U1 snRNA determines the steady-state level of an unstable env pre-mRNA.
    RNA. 2001 Mar;7(3):421-34 PMID: 11333022
  12. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
    Virology. 2001 Aug 1;286(2):276-89 PMID: 11485396
  13. RNA splicing at human immunodeficiency virus type 1 3' splice site A2 is regulated by binding of hnRNP A/B proteins to an exonic splicing silencer element.
    J Virol. 2001 Sep;75(18):8487-97 PMID: 11507194
  14. The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.
    EMBO J. 2001 Oct 15;20(20):5748-58 PMID: 11598017
  15. Functional analysis of the interaction of the human immunodeficiency virus type 1 Rev nuclear export signal with its cofactors.
    Virology. 2003 Sep 30;314(2):591-600 PMID: 14554087
  16. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.
    J Biol Chem. 2004 Mar 12;279(11):10077-84 PMID: 14703516
  17. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    J Virol. 2004 Jun;78(12):6517-26 PMID: 15163745
  18. Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.
    J Virol. 2004 Oct;78(20):11130-41 PMID: 15452233
  19. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.
    J Virol. 1986 Aug;59(2):284-91 PMID: 3016298
  20. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.
    J Virol. 1988 Jan;62(1):139-47 PMID: 3257102
  21. Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.
    J Virol. 1993 Nov;67(11):6365-78 PMID: 8411338
  22. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site.
    J Virol. 1994 May;68(5):3071-9 PMID: 7512159
  23. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
    Mol Cell Biol. 1994 Jun;14(6):3960-70 PMID: 8196635
  24. Splicing variability in HIV type 1 revealed by quantitative RNA polymerase chain reaction.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1531-42 PMID: 7888208
  25. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1.
    Mol Cell Biol. 1995 Aug;15(8):4597-605 PMID: 7623851
  26. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Mol Cell Biol. 1995 Aug;15(8):4606-15 PMID: 7623852
Article Info
Journal
Retrovirology
Abbr.
Retrovirology
ISSN
1742-4690
Published
2006-02-03
Epub
2006-00-03
Pages
10
Language
English
Region
England
NLM ID
101216893
PMCID
PMC1403798
Subset
IM
Grants
NIAID NIH HHS · AI36073 · United States
NIAID NIH HHS · T32 AI007533 · United States
NIAID NIH HHS · R01 AI036073 · United States
NIAID NIH HHS · T32AI007533 · United States
NIAID NIH HHS · R56 AI036073 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]